|
|
||||||||
Receptor
From the Department of Ophthalmology, The Schepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts.
PURPOSE. Contraction of fibroblasts and the resultant tractional force is a contributing factor to fibrotic diseases of the eye, such as proliferative vitreoretinopathy (PVR). Transforming growth factor (TGF)-ß is abundant in the eye, and is one of the growth factors thought to contribute to the development of PVR. A second is platelet-derived growth factor (PDGF). In the current study, the relationship between TGFß1 and PDGF was investigated at the level of cellular contraction.
METHODS. To study cellular contraction, an in vitro type I collagen gel
contraction assay was used with a panel of fibroblast lines that
expressed the PDGF
receptor (
PDGFR) or PDGFß receptor
(ßPDGFR) or no PDGFRs. The agents tested included rabbit vitreous,
TGFß1, and PDGF.
RESULTS. Vitreous promoted cellular contraction, and approximately 60% of this
activity was eliminated by preincubation of the vitreous with
neutralizing TGFß antibodies. The
PDGFR-expressing cells responded
better than cells expressing the ßPDGFR or no PDGFRs. Both of the
PDGFR-expressing cell lines contracted in response to PDGF, whereas the
best response to TGFß1 was observed with cells expressing the
PDGFR. Finally, TGFß1 promoted the tyrosine phosphorylation of
both of the PDGFRs, and the
PDGFR was more strongly phosphorylated
than the ßPDGFR.
CONCLUSIONS. The results show that the vitreous promotes cellular contraction, that
TGFß is the major factor responsible, and that at least a portion of
the TGFß-dependent contraction proceeds through the
PDGFRthat
is, indirectly. Therefore, the
PDGFR is responsible for mediating
cellular contraction of multiple growth factors: TGFß and members of
the PDGF family.
This article has been cited by other articles:
![]() |
M. Brama, S. Basciani, S. Cherubini, S. Mariani, S. Migliaccio, M. Arizzi, G. Rosano, G. Spera, and L. Gnessi Osteoblast-conditioned medium promotes proliferation and sensitizes breast cancer cells to imatinib treatment Endocr. Relat. Cancer, March 1, 2007; 14(1): 61 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zheng, H. Bando, Y. Ikuno, Y. Oshima, M. Sawa, M. Ohji, and Y. Tano Involvement of Rho-Kinase Pathway in Contractile Activity of Rabbit RPE Cells In Vivo and In Vitro Invest. Ophthalmol. Vis. Sci., February 1, 2004; 45(2): 668 - 674. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nakamura, S. Hirano, K. Suzuki, K. Seki, T. Sagara, and T. Nishida Signaling Mechanism of TGF-{beta}1-Induced Collagen Contraction Mediated by Bovine Trabecular Meshwork Cells Invest. Ophthalmol. Vis. Sci., November 1, 2002; 43(11): 3465 - 3472. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ikuno and A. Kazlauskas An In Vivo Gene Therapy Approach for Experimental Proliferative Vitreoretinopathy Using the Truncated Platelet-Derived Growth Factor {alpha} Receptor Invest. Ophthalmol. Vis. Sci., July 1, 2002; 43(7): 2406 - 2411. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |